Utility of methylthioadenosine phosphorylase (MTAP) immunohistochemistry in malignant pleural mesothelioma: correlation with CDKN2A genomic status and inter-assay agreement

被引：0
|
作者：
Zhang, Y. Z. [1 ,2 ]
Hughes, J.
Nastase, A.
Mandal, A.
Brambilla, C.
Rice, A.
Robertus, J. L.
Cookson, W. O.
Moffatt, M. F.
Nicholson, A. G.
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, Natl Ctr Mesothelioma Res, London, England
[2] Royal Brompton & Harefield NHS Fdn Trust, Dept Histopathol, London, England
来源：
VIRCHOWS ARCHIV | 2020年 / 477卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-09-004
引用
收藏
页码：S24 / S24
页数：1
相关论文
共 22 条
  • [1] Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma
    Chapel, David B.
    Dubuc, Adrian M.
    Hornick, Jason L.
    Sholl, Lynette M.
    HISTOPATHOLOGY, 2021, 78 (07) : 1032 - 1042
  • [2] Correlation of MTAP Immunohistochemistry with CDKN2A and MTAP Genomic Alterations in Malignant Mesothelioma
    Sholl, Lynette
    Dubuc, Adrian
    Hornick, Jason
    Chapel, David
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1819 - 1819
  • [3] Correlation of MTAP Immunohistochemistry with CDKN2A and MTAP Genomic Alterations in Malignant Mesothelioma
    Sholl, Lynette
    Dubuc, Adrian
    Hornick, Jason
    Chapel, David
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1819 - 1819
  • [4] Detection of homozygous deletion of CDKN2A and methylthioadenosine phosphorylase (MTAP) by FISH in 95 cases of pleural mesothelioma
    Illei, PB
    Rusch, V
    Ladanyi, M
    LABORATORY INVESTIGATION, 2002, 82 (01) : 321A - 322A
  • [5] Detection of homozygous deletion of CDKN2A and methylthioadenosine phosphorylase (MTAP) by FISH in 95 cases of pleural mesothelioma
    Illei, PB
    Rusch, V
    Ladanyi, M
    MODERN PATHOLOGY, 2002, 15 (01) : 321A - 322A
  • [6] MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma
    Chapel, David B.
    Schulte, Jefree J.
    Berg, Kyra
    Churg, Andrew
    Dacic, Sanja
    Fitzpatrick, Carrie
    Galateau-Salle, Francoise
    Hiroshima, Kenzo
    Krausz, Thomas
    Le Stang, Nolwenn
    McGregor, Stephanie
    Nabeshima, Kazuki
    Husain, Aliya N.
    MODERN PATHOLOGY, 2020, 33 (02) : 245 - 254
  • [7] Correlation of MTAP Immunohistochemistry With CDKN2A Status and Clinicopathological Features in Meningiomas
    Sasaki, Sho
    Takeda, Maiko
    Fujii, Tomomi
    Morita, Kohei
    Ohbayashi, Chiho
    CANCER SCIENCE, 2023, 114 : 461 - 461
  • [8] Comparison of MTAP immunohistochemistry (IHC) with p16/CDKN2A deletions/loss and utility of MTAP and BAP1 IHC in the diagnosis of malignant pleural mesothelioma (MPM)
    Shahi, Maryam
    Eguchi, Takashi
    Zauderer, Marjorie
    Travis, William
    Jungbluth, Achim
    Frosina, Denise
    Fayad, Miriam
    Asher, Marina
    Adusumilli, Prasad S.
    Ladanyi, Marc
    Sauter, Jennifer L.
    MODERN PATHOLOGY, 2018, 31 : 750 - 751
  • [9] Comparison of MTAP immunohistochemistry (IHC) with p16/CDKN2A deletions/loss and utility of MTAP and BAP1 IHC in the diagnosis of malignant pleural mesothelioma (MPM)
    Shahi, Maryam
    Eguchi, Takashi
    Zauderer, Marjorie
    Travis, William
    Jungbluth, Achim
    Frosina, Denise
    Fayad, Miriam
    Asher, Marina
    Adusumilli, Prasad S.
    Ladanyi, Marc
    Sauter, Jennifer L.
    LABORATORY INVESTIGATION, 2018, 98 : 750 - 751
  • [10] Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A: a case report
    Minami, Kazuhiro
    Jimbo, Naoe
    Tanaka, Yugo
    Hokka, Daisuke
    Miyamoto, Yoshifumi
    Itoh, Tomoo
    Maniwa, Yoshimasa
    VIRCHOWS ARCHIV, 2020, 476 (03) : 469 - 473
123